FDA issued a Warning Letter to Fresenius Kabi Oncology Ltd on 12/4/2017 for a later inspection.
483 Fresenius Kabi Oncology Jan 2013

483 Fresenius Kabi Oncology Jan 2013

Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Fresenius Kabi Oncology - Nadia, India facility and issued inspectional observations (via FDA 483) on 18 Jan 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Jan 2013
  • Location: Nadia, India
  • FEI: 3003519498
Add To Cart